Application of Artificial Intelligence Modeling Technology Based on Fluid Biopsy to Diagnose Alzheimer’s Disease
Background: There are no obvious clinical signs and symptoms in the early stages of Alzheimer’s disease (AD), and most patients usually have mild cognitive impairment (MCI) before diagnosis. Therefore, early diagnosis of AD is very critical. This paper mainly discusses the blood biomarkers of AD pat...
Enregistré dans:
Auteurs principaux: | Yuan Sh, Benliang Liu, Jianhu Zhang, Ying Zhou, Zhiyuan Hu, Xiuli Zhang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/39de30a2fedb48b8bac7173c6e7dc2a8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
par: Donoso,Archibaldo, et autres
Publié: (2001) -
Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
par: Zhang N, et autres
Publié: (2018) -
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
par: Chieh-Hsin Lin, et autres
Publié: (2021) -
Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
par: Wang J, et autres
Publié: (2020) -
The Potential of Naturalistic Eye Movement Tasks in the Diagnosis of Alzheimer’s Disease: A Review
par: Megan Rose Readman, et autres
Publié: (2021)